BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9057012)

  • 21. Assay of pyroglutamyl aminopeptidase by high-performance liquid chromatography and its use in peptide sequencing.
    Martini F; Bossa F; Barra D
    Peptides; 1985; 6 Suppl 3():103-5. PubMed ID: 2870471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The development of two fluorimetric assays for the determination of pyroglutamyl aminopeptidase type-II activity.
    Gallagher SP; O'Leary RM; O'Connor B
    Anal Biochem; 1997 Jul; 250(1):1-9. PubMed ID: 9234892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydrolysis of synthetic substrate, L-pyroglutamyl p-nitroanilide is catalyzed solely by pyroglutamyl aminopeptidase I in rat liver cytosol.
    Abe K; Watanabe N; Kosaka T; Yamada M; Tokui T; Ikeda T
    Biol Pharm Bull; 2003 Nov; 26(11):1528-33. PubMed ID: 14600395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [L-pyrrolidone carboxylyl peptidase (author's transl)].
    Daisuke T; Kunio F
    Tanpakushitsu Kakusan Koso; 1980; 25(6):490-9. PubMed ID: 6111106
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of some substrates and potential inhibitors of tissue pyroglutamyl aminopeptidase I.
    Svoboda KS; Currie BL
    Neuropeptides; 1992 Feb; 21(2):85-92. PubMed ID: 1348354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of soluble and membrane-bound pyroglutamyl peptidase I activities in rat brain tissues in the presence of detergents.
    Alba F; Arenas JC; Lopez MA
    Neuropeptides; 1995 Aug; 29(2):103-7. PubMed ID: 7477760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of inhibitors of prolyl endopeptidase and pyroglutamyl peptide hydrolase on TRH degradation in rat serum.
    Friedman TC; Wilk S
    Biochem Biophys Res Commun; 1985 Oct; 132(2):787-94. PubMed ID: 2865955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cloning and heterologous expression of bovine pyroglutamyl peptidase type-1 in Escherichia coli: purification, biochemical and kinetic characterisation.
    Kilbane Z; Vaas PR; Cuív PO; O'Connor B
    Mol Cell Biochem; 2007 Mar; 297(1-2):189-97. PubMed ID: 17119851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble and membrane-bound pyroglutamyl-peptidase I activity in the developing cerebellum and brain cortex.
    de Gandarias JM; Irazusta J; Silio M; Gil J; Saitua N; Casis L
    Int J Dev Biol; 1998 Jan; 42(1):103-6. PubMed ID: 9496793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inactivation of pyroglutamyl aminopeptidase by N alpha-carbobenzoxy-L-pyroglutamyl chloromethyl ketone.
    Fujiwara K; Matsumoto E; Kitagawa T; Tsuru D
    J Biochem; 1981 Aug; 90(2):433-7. PubMed ID: 6117551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Facile analysis and purification of deblocked N-terminal pyroglutamyl peptides with a strong cation-exchange sulfoethyl aspartamide column.
    Crimmins DL; McCourt DW; Schwartz BD
    Biochem Biophys Res Commun; 1988 Oct; 156(2):910-6. PubMed ID: 2903737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prodrugs of peptides. IV: Bioreversible derivatization of the pyroglutamyl group by N-acylation and N-aminomethylation to effect protection against pyroglutamyl aminopeptidase.
    Bundgaard H; Møss J
    J Pharm Sci; 1989 Feb; 78(2):122-6. PubMed ID: 2565975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further characterization of the substrate specificity of a TRH hydrolysing pyroglutamate aminopeptidase from guinea-pig brain.
    Elmore MA; Griffiths EC; O'Connor B; O'Cuinn G
    Neuropeptides; 1990 Jan; 15(1):31-6. PubMed ID: 1970134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for the enzymic degradation of thyrotropin-releasing-hormone (TRH) and pseudo-hormone (pyroglutamyl-histidyl-amphetamine) by calf liver pyroglutamine-amino-peptidase.
    Morier E; Moreau O; Masson MA; Han KK; Rips R
    Int J Biochem; 1979; 10(9):769-83. PubMed ID: 39805
    [No Abstract]   [Full Text] [Related]  

  • 35. Occurrence of the free and Peptide forms of pyroglutamic acid in plasma from the portal blood of rats that had ingested a wheat gluten hydrolysate containing pyroglutamyl peptides.
    Higaki-Sato N; Sato K; Inoue N; Nawa Y; Kido Y; Nakabou Y; Hashimoto K; Nakamura Y; Ohtsuki K
    J Agric Food Chem; 2006 Sep; 54(19):6984-8. PubMed ID: 16968052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of acute lithium administration on pyroglutamyl-aminopeptidase I activity in several brain areas of the rat.
    de Gandarias JM; Irazusta J; Gil J; Fernández D; Casis L
    Arzneimittelforschung; 1994 Feb; 44(2):119-21. PubMed ID: 7908521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroid status influences rat serum but not brain TRH pyroglutamyl aminopeptidase activities.
    Emerson CH; Wu CF
    Endocrinology; 1987 Mar; 120(3):1215-7. PubMed ID: 2879728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-alpha-carbobenzoxy pyroglutamyl diazomethyl ketone as active-site-directed inhibitor for pyroglutamyl peptidase.
    Fujiwara K; Matsumoto E; Kitagawa T; Tsuru D
    Biochim Biophys Acta; 1982 Apr; 702(2):149-54. PubMed ID: 6123347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New chromogenic and fluorogenic substrates for pyrrolidonyl peptidase.
    Fujiwara K; Tsuru D
    J Biochem; 1978 Apr; 83(4):1145-9. PubMed ID: 26673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyroglutamate aminopeptidase in rat submaxillary gland.
    Bharadwaj D; Roy MS; Saha G; Hati RN
    Indian J Biochem Biophys; 1992 Oct; 29(5):442-4. PubMed ID: 1363235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.